General |
Implementation research |
6,9 |
1,07 |
General |
HIV prevention, general |
0,0 |
1,24 |
HIV andtuberculosis |
Studies on provision of screening of TB patients for HIV |
0,0 |
1,21 |
HIV andtuberculosis |
Identification of best strategies for the co-management of TB and HIV care |
0,0 |
1,29 |
HIV Care |
Paediatriccoverage |
3,7 |
1,14 |
HIV Care |
Identification of socio-economic, behavioural, cultural, structural and other factors that have an impact on ART access and can be influenced by the programme |
3,7 |
1,17 |
HIV epidemiology |
Proportion of individuals becoming newly infected (incidence) |
3,6 |
1,11 |
HIV prevention |
Evaluation of combination of prevention approaches |
3,4 |
1,24 |
Monitoring, datausage |
Comprehensive inventory of publicly available data on HIV/AIDS |
7,1 |
1,24 |
Monitoring, datausage |
Studies on utilization of data |
0,0 |
1,28 |
PMTCT |
Evaluation of combination of prevention approaches |
0,0 |
1,28 |
PMTCT |
Early infant diagnosis – what is the proportion of mothers receiving test results |
7.1 |
1.32 |
HIV care |
Screening for cervical intraepithelial lesions (PAP) |
25,0 |
1,14 |
HIV care |
Contributionof private sector |
14,8 |
1,28 |
HIV epidemiology |
Numbers of individuals requiring ART |
10,7 |
1,29 |
HIV support |
Have workplace programs affected stigma and discrimination at the workplace |
29,6 |
1,03 |
HIV support |
To what extent does access to treatment promote HIV disclosure? |
10,7 |
1,24 |
PMTCT |
Identification of best strategies for provision and monitoring of CD4 testing and treatment for pregnant and breastfeeding women |
10,7 |
1,18 |
PMTCT |
Factors influencing the retention of care in the first 12 months of life |
14,3 |
1,29 |
PMTCT |
To what extent are recommendations regarding feeding options are understood by the service providers at different levels in the health delivery system |
32,1 |
1,29 |